Workday, Inc. provides enterprise cloud applications for finance and human resources in the United States and internationally. It offers applications for customers to manage critical business functions that enable them to optimize their financial and human capital resources. The company provides Workday Human Capital Management application that includes global human resources management comprising workforce lifecycle management, organization management, compensation, absence, and employee benefits administration; and global talent management consisting of goal management, performance management, succession planning, and career and development planning, as well as project and work management designed to enable organizations to create and manage and track initiatives, build project plans, and utilize project breakdown structures that include phases, tasks, and milestones. It also offers Workday Payroll, a payroll application designed to address the enterprise payroll needs; and Workday Financial Management tools that provide the core finance functions of general ledger, global accounting, revenue management, accounts payable, employee expense management, and accounts receivable, along with tools to help organizations manage their cash, assets, contracts, grants, expenses, procurement, and support their financial reporting requirements, as well as offer management reporting and analysis in real time. In addition, the company provides Workday Insight Applications that leverage advanced data science and machine learning methodologies to help customers make smarter financial and workforce decisions. It serves technology, financial services, business services, healthcare and life sciences, manufacturing, consumer and retail, and education and government industries. The company was formerly known as North Tahoe Power Tools, Inc. and changed its name to Workday, Inc. in July 2005. Workday, Inc. was founded in 2005 and is headquartered in Pleasanton, California.
Phibro Animal Health Corporation operates as a diversified animal health and mineral nutrition company in the United States, Israel, Latin America, Canada, Europe, Africa, and the Asia Pacific. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets animal health products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture. Its animal health products include antibacterials that are biological or chemical products used in the animal health industry to treat or to prevent diseases; anticoccidials to prevent and control the disease coccidiosis in poultry and cattle; anthelmintics for treating infestations of parasitic intestinal worms; anti-bloat treatment products used in cattle to control bloat in animals grazing on legume, or wheat-pasture; and medicated feed additives and other related products. The company's animal health products also comprise nutritional specialty products, which enhance nutrition to help improve health and performance; and vaccines to prevent diseases primarily in the poultry and swine industries. In addition, it manufactures and markets approximately formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds. The company sells its animal health and mineral nutrition products directly to integrated poultry, swine, and cattle integrators, as well as through commercial animal feed manufacturers, wholesalers, and distributors. Further, it manufactures and markets a range of specialty ingredients for use in the personal care, automotive, industrial chemical, and chemical catalyst industries through its local sales offices. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation is headquartered in Teaneck, New Jersey.
Bridge Bancorp, Inc. operates as the bank holding company for The Bridgehampton National Bank that provides commercial and consumer banking services in the United States. Its deposit products include time, savings, and demand deposits; and certificates of deposit, as well as NOW and money market deposits. The company also provides various loans comprising commercial real estate mortgage loans, multi-family mortgage loans, residential real estate mortgage loans, construction loans, home equity loans, land loans, and installment and consumer loans, as well as commercial, industrial, and agricultural loans. In addition, it offers merchant credit and debit card processing, automated teller machines, cash management services, lockbox processing, online banking services, remote deposit capture, safe deposit boxes, individual retirement accounts, and investment products and services through a third party broker dealer. Further, the company operates as a broker of title insurance services. It primarily serves small businesses, municipal relationships, and consumer relationships. As of April 3, 2015, it operated 29 retail branches in the market areas of Suffolk and Southern Nassau counties, Long Island. Bridge Bancorp, Inc. was founded in 1910 and is headquartered in Bridgehampton, New York.
TubeMogul, Inc. operates as an enterprise software company for digital branding. It offers a cloud-based platform that enables advertisers to plan, buy, measure, and optimize video advertising spend from a single platform. The company provides its platform through two offerings, Platform Direct that allows advertisers to run campaigns through a self-serve model; and Platform Services, which allows advertisers to specify campaign objectives. TubeMogul, Inc. was founded in 2007 and is headquartered in Emeryville, California.
Otonomy, Inc. develops and commercializes therapeutics for the treatment of ear diseases and disorders primarily in the United States. Its lead product candidate is AuriPro, a sustained-exposure antibiotic, which is in Phase III clinical trials to treat pediatric patients with middle ear effusion at the time of tympanostomy tube placement surgery. The company also develops OTO-104, a sustained-exposure formulation of the steroid dexamethasone that is in a Phase IIb clinical trial for the treatment of patients with Mnire's disease; and OTO-311, a sustained-exposure formulation of N-methyl-D-aspartate receptor antagonist gacyclidine, which is in preclinical development as a potential treatment for tinnitus. Otonomy, Inc. was founded in 2008 and is headquartered in San Diego, California.
salesforce.com, inc. provides enterprise cloud computing solutions, with a focus on customer relationship management to various businesses and industries worldwide. The company offers enterprise cloud computing apps and platform services, including Sales Cloud for sales force automation, which enables companies to store data, access accurate customer and prospect information, track leads and progress, forecast opportunities, and collaborate around any sale on desktop and mobile devices; Service Cloud that enables companies to connect address customers service and support needs; and Marketing Cloud, which enables companies to map customer journeys to digital marketing interactions through email, mobile, social, Web, and connected products. It also provides Community Cloud, a platform to engage specific group of people with access to relevant information, apps, and experts; Analytics Cloud, an app and platform to deploy sales, service, marketing, and custom analytics apps using any data source; Salesforce1 Platform, a cloud platform to build apps that manage various business processes. In addition, the company provides professional services, including consulting, deployment, training, implementation, and integration services to facilitate the adoption of its cloud solutions. It sells and markets its services primarily through its direct sales force, as well as through global consulting firms, systems integrators, and regional partners. salesforce.com, inc. was founded in 1999 and is headquartered in San Francisco, California.
ResMed Inc. develops, manufactures, distributes, and markets medical equipment for the diagnosis, treatment, and management of respiratory disorders with a focus on sleep-disordered breathing (SDB). Its products include airflow generators, such as CPAP, VPAP and AutoSet systems for the titration and treatment of SBD; and masks, motors, and diagnostic products. The company also offers accessories and other products, such as humidifiers, carry bags, and breathing circuits, as well as data communications and control products, including EasyCare, ResLink, ResControl, ResControl II, TxControl, ResScan, and ResTraxx modules that facilitate the transfer of data and other information to and from the flow generators. ResMed Inc. markets its products to sleep clinics, hospitals, home healthcare dealers, and third-party payers. The company sells its products through a network of distributors and direct sales force in approximately 100 countries internationally. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
Entravision Communications Corporation, operates as a diversified media company that utilizes a combination of television, radio, and digital media properties to reach Hispanic consumers in the United States and the border markets of Mexico. The company operates in three segments: Television Broadcasting, Radio Broadcasting, and Digital Media. It owns and operates television stations that broadcast drama shows, talk shows, novellas, entertainment magazines, news magazines, national news, specials, late news, children's programs, sports, reality, comedy shows, and movies. The company also owns and operates radio stations that broadcast advertising, news, traffic, weather, promotions, and community events. In addition, it operates a proprietary technology and data platform that delivers digital advertising solutions in various advertising formats. As of December 31, 2014, the company owned and/or operated 58 primary television stations located primarily in California, Colorado, Connecticut, Florida, Kansas, Massachusetts, Nevada, New Mexico, Texas, and Washington, D.C.; and 49 operational radio stations consisting of 38 FM and 11 AM in 19 markets located primarily in Arizona, California, Colorado, Florida, Nevada, New Mexico, and Texas. Entravision Communications Corporation was founded in 1996 and is headquartered in Santa Monica, California.
Monolithic Power Systems, Inc. designs, develops, and markets integrated power semiconductor solutions and power delivery architectures for communications, storage and computing, consumer electronics, and industrial/automotive markets. The company primarily provides digital, analog, and mixed-signal integrated circuits (ICs). It offers direct current (DC) to DC converter ICs that are used to convert and control voltages of various electronic systems, such as portable electronic devices, wireless LAN access points, computers, set top boxes, TVs and monitors, automobiles, and medical equipment. The company also provides lighting control ICs for backlighting that are used in systems, which provide the light source for LCD panels in notebook computers, LCD monitors, car navigation systems, and LCD televisions. In addition, it offers alternating current (AC)/DC offline solutions for lighting illumination applications; and AC/DC power conversion solutions for various end products that plug into a wall outlet. The company markets its products through third party distributors, value-added resellers, and directly to original equipment manufacturers, original design manufacturers, and electronic manufacturing service providers in China, Taiwan, Europe, Korea, Southeast Asia, Japan, the United States, and internationally. Monolithic Power Systems, Inc. was founded in 1997 and is headquartered in San Jose, California.
Corcept Therapeutics Incorporated, a pharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of metabolic, oncologic, and psychiatric disorders in the United States. The company focuses on disorders that are associated with a steroid hormone called cortisol. It offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome, who have type 2 diabetes mellitus or glucose intolerance, and have failed surgery or are not candidates for surgery. The company is also developing Korlym's active ingredient, which is in a Phase 1/2 trial in combination with the chemotherapy drug eribulin (Halaven) to treat patients with GR-positive triple-negative breast cancer, a form of cancer with a particularly poor prognosis; and CORT 125134, a proprietary, selective GR antagonist that is in a Phase 1 clinical study to assess its safety, tolerability, and pharmacokinetics in healthy human volunteers. In addition, it discovers and develops three series of novel selective GR-II antagonists. The company has research and development agreements with Argenta Discovery Limited and Sygnature Discovery Limited. Corcept Therapeutics Incorporated was founded in 1998 and is headquartered in Menlo Park, California.